David Bharucha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting

Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesIsrael generalKevin gardnerDavid bharuchaKim foxChris calabreseUs securities exchange commissionJournal of the american college cardiologyMilestone pharmaceuticalsPharmaceuticals incAmerican college of cardiology annual meetingMilestone pharmaceuticals incExchange commissionSelf manage recurringAmerican collegeCardiology annual

Milestone® Pharmaceuticals Announces Etripamil Data

Data from this large safety-trial also published in The Journal of the American College of Cardiology.

Israel generalUnited statesDavid bharuchaChris calabreseKevin gardnerKim foxMilestone pharmaceuticals incUs securities exchange commissionPharmaceuticals incExchange commissionMilestone pharmaceuticalsJournal of the american college cardiologyChief medical officerSouth americaAmerican collegeCardiology scientific sessions

Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences

Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesKim foxChris calabreseKevin gardnerJames ipDavid bharuchaAmerican college of cardiologyMilestone pharmaceuticals incDivision of cardiologyEuropean heart rhythm associationMilestone pharmaceuticalsPharmaceuticals to present data on etripamilPharmaceuticals incEuropean heart rhythm association annual conferencesPresent dataAmerican college

Milestone Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences

Milestone Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesDavid bharuchaKim foxJames ipAmerican college of cardiologyDivision of cardiologyMilestone pharmaceuticals incMilestone pharmaceuticalsEuropean heart rhythm associationAmerican collegePresentation titleOpen label studyCardiac pacingImplantable devicesWeill cornell medicineNew york presbyterian hospital

Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023

Milestone Pharmaceuticals Inc. recently announced positive Phase 2 data that show etripamil nasal spray resulted in rapid and statistically superior ventricular rate reduction and improved symptom-relief in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) compared to placebo. The findings were presented during the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA.

City ofUnited kingdomUnited statesOlmsted countyA john cammDavid bharuchaCardiology clinical academic groupMilestone pharmaceuticals incClinical sciences research instituteDuring the american heart association scientific sessionsMilestone pharmaceuticalsAmerican heart association council on epidemiologyGeorge university of londonPrevention statistics committeeA report from the american heart associationDrug administration